Skip to main content
Clinical Trials/ISRCTN37589515
ISRCTN37589515
Completed
Not Applicable

A phase II randomised controlled trial assessing the feasibility, acceptability and potential effectiveness of Dignity Therapy for older people in care homes

King's College London (UK)0 sites64 target enrollmentJanuary 30, 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
King's College London (UK)
Enrollment
64
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 30, 2009
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
King's College London (UK)

Eligibility Criteria

Inclusion Criteria

  • Residents (males and females) aged 65 years old or over, living in one of six care homes for older people, are included. Not all residents have a terminal illness and they are not selected on the basis of receiving palliative care. However, all residents in nursing homes are frail and could be considered as reaching the end of life. Participants are not screened for spiritual or psychological distress, or loss of dignity, however, these are assessed at baseline, to explore the potential moderating effects of these variables on the impact of the intervention.

Exclusion Criteria

  • 1\. Residents who are considered by the care home managers to be too ill to be interviewed
  • 2\. Unable to provide informed consent either due to cognitive problems, or to the severity of their illness, or because they are unable to understand English

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
An exploratory study of Dignity Therapy for people with advanced cancerAdvanced cancerCancerMalignant neoplasm of other and ill-defined sites
ISRCTN29868352King's College London (UK)40
Recruiting
Phase 2
Dose escalation trial for squamous cell carcinoma of head and neck using FMISO PET CTHealth Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
CTRI/2024/04/065373Varian Medical Systems Inc
Completed
Not Applicable
Enhancing decision-making about treatment in bipolar II disorder: Evaluation of a treatment decision-aid for patients and their family.Bipolar II disorderMental Health - Other mental health disorders
ACTRN12617000840381A/Prof Ilona Juraskova196
Not yet recruiting
Phase 2
The effects of novel medicinal cannabis formulation IHL-42X on apnoea hypopnea index in adults with suspected or diagnosed mild to moderate obstructive sleep apnoea.
ACTRN12619001103156Cannvalate30
Active, not recruiting
Not Applicable
Clinical trial to determinate viral load in seminal fluid in HIV-positive patients without previous treatmentHIV-1 infectionMedDRA version: 17.1Level: LLTClassification code 10068341Term: HIV-1 infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 17.1Level: PTClassification code 10020161Term: HIV infectionSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Virus Diseases [C02]
EUCTR2014-001348-39-ESFundación pública andaluza para la gestión de la investigación en salud de Sevilla (FISEVI)